Accrued liabilities as of March 31, 2024 and December 31, 2023 consisted of the following:
March 31,
December 31,
2024
2023
Accrued personnel related costs
$
1,144
1,989
Accrued research and development expenses
8,052
6,527
Other accrued expenses
123
313
Total
9,319
8,829
No definition available.
Tabular disclosure of the components of accrued liabilities.